Endocan: A biomarker for endothelial dysfunction and inflammation, linking maternal obesity and pediatric obesity in a cohort of preterm neonates

The prevalence of obesity in reproductive aged women in the United States is approaching 40  %, and is thus the most common risk factor for pregnancy complications [1,2]. It has been well established that maternal obesity in pregnancy is associated with increased risks for the mother and the neonate. Maternal risks include gestational diabetes, preeclampsia, sleep apnea, cesarean section , venous thromboembolism, wound dehiscence, and epidural anesthesia failure [2,3]. Fetal and neonatal risks include congenital anomalies, difficulty in ultrasonographic diagnosis of anomalies, increased likelihood of cell free fetal DNA testing failure, miscarriage, stillbirth, and infant mortality [2–4].
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - Category: OBGYN Authors: Tags: Full length article Source Type: research